Delivery Order SPE2DB20D2104-SPE2DB26FMBBX
Award Date 10/28/25
Potential Completion Date 10/29/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml units) with a ceiling value of $12,701.74. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under the company's larger...
- The Defense Logistics Agency awarded a $3,385.80 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml pharmaceutical products. This firm fixed-price, non-set-aside contract is scheduled for completion by September 23, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within AmerisourceBergen's broader federal contract portfolio and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml) with a contract ceiling value of $2,770.57. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 29, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,564.64 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml) on November 3, 2025, with completion scheduled for November 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the vendor's ongoing pharmaceutical supply relationship with the federal government. The contract is performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,346.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pulmozyme 1 mg/ml ampuls in 2.5 ml units. The contract, with an ultimate completion date of September 15, 2025, carries no set-aside designation and represents a competitive award under AmerisourceBergen's existing federal pharmaceutical supply agreements. Performance will be executed from the contractor's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 21, 2025, for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml units) with a ceiling value of $14,886.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made without set-aside designations, reflecting the contractor's demonstrated...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampul 2.5ml on September 12, 2025, with a ceiling value of $5,167.20 and firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 15, 2025. The award represents a continuation of AmerisourceBergen's significant role as a critical pharmaceutical supplier to federal military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,152.50 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pulmozyme 1 mg/ml ampule 2.5ml. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on September 17, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Pulmozyme 1 mg/mL ampul 2.5mL with a ceiling value of $4,280.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is scheduled for ultimate completion on May 21, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $13,882.26 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/mL ampules (2.5 mL) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete delivery of this specialty...